Citação norma APA

Giessen, C., von Weikersthal, L. F., Hinke, A., Stintzing, S., Kullmann, F., Vehling-Kaiser, U., . . . Heinemann, V. (2011). A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial. BioMed Central.

Citação norma Chicago

Giessen, Clemens, et al. A Randomized, Phase III Trial of Capecitabine Plus Bevacizumab (Cape-Bev) Versus Capecitabine Plus Irinotecan Plus Bevacizumab (CAPIRI-Bev) in First-line Treatment of Metastatic Colorectal Cancer: The AIO KRK 0110 Trial/ML22011 Trial. BioMed Central, 2011.

Citação norma MLA

Giessen, Clemens, et al. A Randomized, Phase III Trial of Capecitabine Plus Bevacizumab (Cape-Bev) Versus Capecitabine Plus Irinotecan Plus Bevacizumab (CAPIRI-Bev) in First-line Treatment of Metastatic Colorectal Cancer: The AIO KRK 0110 Trial/ML22011 Trial. BioMed Central, 2011.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.